Quinine sulfate and bacterial invasion

Annals of Clinical Microbiology and Antimicrobials

Volumn 1, Issue , 2002, Pages

  Wolf, Ronni ^a   Baroni, Adone ^b   Greco, Rita ^b   Donnarumma, Giovanna ^b   Ruocco, Eleonora ^b   Tufano, Maria Antonietta ^b   Ruocco, Vincenzo ^b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; QUININE SULFATE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM CULTURE; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; HELA CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INCUBATION TIME; INFECTION PREVENTION; INOCULATION; MONOLAYER CULTURE; NONHUMAN;

EID: 3042656627     PISSN: 14760711     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-0711-1-5     Document Type: Article

References (28)

1. Isaacson D, Elgart M, Turner M: Antimalarials in dermatology. Int J Dermatol 1982, 21:379-395
2. Wallace D: The history of antimalarials. Lupus 1996, 5(Suppl 1):S2-S3
3. Greenwood B, Greenwood A, Bradley A, Tulloch S, Hayes R, Oldfield F: Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. Ann Trop Pediatr 1987, 7:91-99
4. Wolf R, Wolf D, Ruocco V: Antimalarials: unapproved uses or indications. Clin Dermatol 2000, 18:17-35
5. Isberg R, Vorhis D, Falkow S: Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 1987, 50:769-778
6. Conte M, Mastromarino P, Nicoletti M, Visca P, Valenti P, Seganti L: Effect of polyelectrolytes on entry of Escherichia coli HB101 (pR1203) into HeLa cells. Microb Pathog 1990, 9:191-198
7. Isberg R, Falkow S: A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 1985, 317:262-264
8. Chiang G, Sassaroli M, Louie M, Chen H, Stecher V, Sperber K: Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zodovudine. Clin Ther 1996, 18:1080-1092
9. Savarino A, Gennero L, Ehen H, Serrano D, Malavasi F, Boelaert J, Sperber K: Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS 2001, 15:2221-2229
10. Savarino A, Gennero L, Sperber K, Boelaert J: The anti-HIV-1 activity of chloroquine. J Clin Virol 2001, 20:131-135
11. Boelaert J, Piette J, Sperber K: The potential place of chloroquine in the treatment of HIV-1-infected patients. J Clin Virol 2001, 20:137-140
12. Boelaert J, Sperber K, Piette J: The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea. Biochem Pharmacol 2001, 61:1531-1535
13. Smith K, Dawes I: The preferential inhibition of Bacillus subtillis spore outgrowth by chloroquine. Arch Microbiol 1989, 152:251-257
14. Crowle A, May M: Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3. Antimicrob Agents Chemother 1990, 34:2217-2222
15. Byrd T, Horwitz M: Chloroquine inhibits the intracellular multiplication of Legionella pneumophilia by limiting the availability of irom. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest 1991, 88:351-357
16. Newman S, Gootee L, Brunner G, Deepe G: Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intacellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest 1994, 93:1422-1429
17. Fortier A, Leiby D, Narayanan R, Asafoadjei E, Crawford R, Nacy C, Meltzer M: Growht of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect Immun 1995, 63:1478-1483
18. Levitz S, Harrison T, Tabuni A, Liu X: Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by mechanism independent of iron deprivation. J Clin Invest 1997, 100:1640-1646
19. Coppens I, Sinai A, Joiner K: Toxoplasma gondii exploits host low-density lipoprotein receptor mediated endocytosis for cholesterol acquisition. J Cell Biol 2000, 149:167-180
20. Boelaert J, Appelberg R, Gomes M, Blasi E, Mazzolla R, Grosset J, Lounis N, Soteriadou K, Thiakaki M, Taramelli D, Tognazioli C: Experimental results on chloroquine and AIDS-related opportunistic infections. J Acquired Immun Def Syndr 2001, 26:300-301
21. Wiseman D: The uptake of chloroquine by Eshcericia coli. J Pharm Pharmacol 1972, 24(Suppl):161P
22. Wiseman D: The effect of pH on the inhibitory acrivity of chloroquine against Eshcerichia coli. J Pharm Pharmacol 1972, 24(Suppl):162P
23. Middleton K, Wiseman D: Proceeings: The effect of chloroquine on the growth and viability of Eshcerishia coli. J Pharm Pharmacol 1974, 26(Suppl):99P-100P
24. Middleton K, Wiseman D: The effect of chloroquine on macromolecule synthesis and oxygen uptake in Eshcericia coli [proceedings]. J Pharm Pharmacol 1979, 31(Suppl):31P
25. Whichard L, Washington M, Holbrook J: The inhibition in vitro of bacterial DNA polymerases and RNA polymerase by antimalarial 8-aminoquinolines and by chloroquine. Biochim Biophys Acta 1972, 287:52-67
26. Cohen S, Yielding K: Inhibition of DNA and RNA polymerase reactions by chloroquine. Proc Natl Acad Sci USA 1965, 54:521-527
27. O'Brien R, Olnenick J, Hahn F: Reactions of quinine, chloroquine, and quinacrine with DNA and their effects on the DNA and RNA polymerase reactions. Proc Natl Acad Sci USA 1966, 55:1511-1517
28. Straube E, Schmidt G, Marre R, Hacker J: Adhesion and internalization of E. coli strains expressing various pathogenicity determinants. Zentralbl Bakteriol 1993, 278:218-228